source
- Alkermes CEO targets orexin market after strong narcolepsy pill dataAlkermes' incoming chief executive outlined a strategy to compete with larger rivals in the emerging orexin drug class. Recent mid-June trial results showed the experimental oral compound alixorex…
- FDA advisory panel backs Moderna's experimental flu vaccine in adults 50-64, supports accelerated review for 65+The FDA's advisory committee voted unanimously to recommend Moderna's mRNA-1010 flu vaccine for adults aged 50 to 64, and also found it beneficial for those 65 and older. The 9-0 vote allows Moder…